Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Preferred Stock Liabilities: 2013

Historic Preferred Stock Liabilities for Ocular Therapeutix (OCUL) over the last 1 years, with Dec 2013 value amounting to $74.3 million.

  • Ocular Therapeutix's Preferred Stock Liabilities was N/A to $74.4 million in Q2 2014 from the same period last year, while for Jun 2014 it was $74.4 million, marking a year-over-year change of. This contributed to the annual value of $74.3 million for FY2013, which is N/A change from last year.
  • Latest data reveals that Ocular Therapeutix reported Preferred Stock Liabilities of $74.3 million as of FY2013.
  • Ocular Therapeutix's 5-year Preferred Stock Liabilities high stood at $74.3 million for FY2013, and its period low was $74.3 million during FY2013.
  • Moreover, its 1-year median value for Preferred Stock Liabilities was $74.3 million (2013), whereas its average is $74.3 million.